MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    α-Synuclein Seed Amplification Assay Amplification Parameters and Progression in Parkinson’s Disease

    D. Coughlin, B. Shifflett, A. Siderowf, S. Edland, D. Galasko, C. Farris, Y. Ma, C. Soto, L. Concha-Marambio (San Diego, USA)

    Objective: To examine the relationship between the reaction parameters of the cerebrospinal fluid (CSF) αSyn seed amplification assay (αSyn-SAA) to the risk of developing motor…
  • 2024 International Congress

    Increased cholinergic activity in specific brain regions associated with the presence of dyskinesias in Parkinson’s disease: A [18F]-FEOBV PET study

    N. Bohnen, G. Carli, F. Michalakis, C. Pongmala, M. Emde Boas, R. Albin, P. Kanel (Ann Arbor, USA)

    Objective: To explore the role of cholinergic dysfunction in dyskinesia symptoms in people with Parkinson’s disease (PD). Background: Dyskinesias, involuntary and sometimes excessive or uncontrolled…
  • 2024 International Congress

    Parkinson Disease. An innovative Aproach

    M. Martinovic, G. Montado, R. Aljanati (Montevideo, Uruguay)

    Objective: Aims: promoting maximum autonomy, potentiating resources, improve functionality, stimulating activity, preventing complications. Background: Since 2006, the Program has operated uninterruptedly, even during COVID-19. Aimed…
  • 2024 International Congress

    Hospital Care Learning Collaborative: Sharing strategies to address the Parkinson’s Foundation Inpatient Clinical Care Standards

    A. Brooks, E. Buetow, H. Azmi, B. Walter, K. Amodeo, P. Pronovost (Miami, USA)

    Objective: The Parkinson’s Foundation made another significant step toward its vision to eliminate preventable harm and promote higher reliability in care with the launch of…
  • 2024 International Congress

    SelfCog®: A 15-min Digitized Cognitive Battery To Measure Cognitive Deficit In Parkinson Disease (PD) Patients

    J. Montillot, A. Gil-Salcedo, R. Massart, M. Lunven, A. Petit, A. Dormeuil, H. Salhi, A. Bachoud-Lévi, P. Rémy (Créteil, France)

    Objective: Use a news automated, motor-controlled cognitive battery, the SelfCog®, to compare cognitive deficits in PD patients. Background: Mild cognitive impairment (MCI) is a major…
  • 2024 International Congress

    Cleaved plasma kininogen is associated with unfavorable cognitive outcome in Parkinson’s disease

    I. Markaki, T. Ntetsika, W. Paslawski, P. Tsitsi, S. Carvalho, JC. Corvol, P. Svenningsson (Stockholm, Sweden)

    Objective: The aim of this study was to examine the association between kininogen cleavage in plasma and cognitive outcome in Parkinson’s disease (PD). Background: No…
  • 2024 International Congress

    A Nomogram Model for Predicting Malnutrition among Patients with Parkinson’s Disease

    Q. Huang, X. Zou (Chengdu, China)

    Objective: This study aims to develop and validate a Nomogram prediction model for assessing malnutrition risk in PD patients. Background: Parkinson's disease (PD) is a…
  • 2024 International Congress

    Odor-specific symptoms in Parkinson’s disease – UPSIT odor identification status versus clinical severity.

    YG. Guo, SC. Chiu (Taichung, Taiwan)

    Objective: To explore correlations between the identification status of individual odors in the Pennsylvania Smell Identification Test (UPSIT) and the clinical severity of Parkinson’s disease…
  • 2024 International Congress

    Orthostatic Hypotension:a Clinical Marker for the Body-First Subtype of Patients with Parkinson’s Disease

    S. Mei, X. Wang, C. Han, P. Chan (Beijing, China)

    Objective: Our study aimed to investigate the clinical characteristics of PD patients stratified by OH status before and after levodopa challenge to explore the hypothesis…
  • 2024 International Congress

    Prevalence of Helicobacter Pylori Infection Among Nepalese Parkinson’s Disease Patients and their Clinical Manifestations

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, R. Hamal, A. Jha, R. Pathak (Kathmandu, Nepal)

    Objective: To know the prevalence of Helicobacter Pylori infection among Nepalese Parkinson´s Disease patients and understand their clinical characteristics Background: Helicobacter pylori (HP) is prevalent…
  • « Previous Page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley